Highly active antiretroviral therapy decreases the incidence of bacteremia in human immunodeficiency virus-infected individuals.
Tacconelli
E
E
Department of Infection Diseases, Catholic University, Roma, Italy.
Tumbarello
M
M
de Gaetano
K
K
Cauda
R
R
Ortona
L
L
D017088:AIDS-Related Opportunistic Infections / Q000453:epidemiology* / Q000276:immunology; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000453:epidemiology* / Q000276:immunology; D016022:Case-Control Studies; D004359:Drug Therapy, Combination; D005260:Female; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D008297:Male; D011446:Prospective Studies; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D012309:Risk-Taking
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors